| Literature DB >> 26404216 |
Stella A Ordoudi1, Anastasia Kyriakoudi2, Maria Z Tsimidou3.
Abstract
The present study aims to examine whether and to what extent the bioaccessibility of the major saffron apocarotenoids, namely crocetin sugar esters (CRTSEs), is affected by the presence of strong water-soluble antioxidants, ingredients of the herbs found in commercial tea blends with saffron. An in vitro digestion model was applied to infusions from these products to investigate the possible changes. All of the studied infusions were rich in total phenols (9.9-22.5 mg caffeic acid equivalents/100 mg dry infusion) and presented strong DPPH radical scavenging activity regardless of the composition of the corresponding herbal blends. RP-HPLC-DAD and LC-MS analysis enabled the grouping of the infusions into hydroxycinnamic acid-rich and in flavan-3-ol-rich ones. CRTSEs in herbal tea infusions were found to be significantly more bioaccessible (66.3%-88.6%) than those in the reference saffron infusion (60.9%). The positive role of strong phenolic antioxidants (caffeic acid, rosmarinic acid) on the stability of CRTSEs was also evidenced in model binary mixtures. On the contrary, cinnamic acid, exerting no antioxidant activity, did not have such an effect. Our findings suggest that strong radical scavengers may protect the crocetin sugar esters from oxidation during digestion when present in excess.Entities:
Keywords: bioaccessibility; crocetin sugar esters; in vitro digestion; phenolic antioxidants; saffron infusions
Mesh:
Substances:
Year: 2015 PMID: 26404216 PMCID: PMC6332399 DOI: 10.3390/molecules201017760
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The % bioaccessibility of total crocetin sugar esters (CRTSEs) in infusions of saffron and herbal tea blends with saffron (A–E). Data are the mean values of three independent experiments. Different lowercase letters (a–c) indicate significant differences among infusions according to Duncan’s test (p < 0.05).
Figure 2(a) Total phenol content (expressed as caffeic acid equivalents, CA) and (b) DPPH radical scavenging activity (expressed as rosmarinic acid equivalents, RA) of Infusions A–E. Data are the means of three independent measurements ± SD; different lowercase letters (a–c) indicate significant differences among infusions according to Duncan’s test (p < 0.05).
The % bioaccessibility of crocetin sugar esters (CRTSEs) and rosmarinic acid (RA) in model mixtures upon simulated gastrointestinal conditions.
| CRTSEs: Rosmarinic Αcid ( | % Bioaccessibility a,b | |
|---|---|---|
| CRTSEs | Rosmarinic Αcid | |
| 1:12 | 79.6 ± 6.7 b | 89.6 ± 5.1 a |
| 1:6 | 76.9 ± 4.1 b | 88.8 ± 2.3 a |
| 1:3 | 77.7 ± 4.0 b | 84.8 ± 3.3 a |
| 1:0 | 60.1 ± 4.9 a | - |
a Values are expressed as the mean ± SD; b different lower case letters within the same column indicate significant differences according to Duncan’s test (p < 0.05).
The % bioaccessibility of CRTSEs and of selected phenolic compounds upon simulated gastrointestinal conditions.
| Model Solution Composition | Bioaccessibility a,b | |
|---|---|---|
| % Crocetin Esters | % Phenolic Compound | |
| CRTSEs c:caffeic acid d | 87.6 ± 5.5 c | 95.2 ± 3.6 |
| CRTSEs c:cinnamic acid d | 49.5 ± 1.9 a | 89.3 ± 6.8 |
| CRTSEs c:rosmarinic acid d | 78.7 ± 1.0 b | 84.9 ± 4.5 |
| Reference sample | 51.6 ± 1.5 a | - |
a Values are expressed as the mean ± SD; b different lowercase letters (a–c) within the same column indicate significant differences according to Duncan’s test (p < 0.05); c 4.7 µM as trans-4-GG crocetin ester; d 85 µM of rosmarinic acid, caffeic acid or cinnamic acid.
Contents of total hydroxycinnamic acids and rosmarinic acid (330 nm) of Infusions A–C, as well as flavan-3-ols (270 nm) and (−)-epicatechin of infusions D and E (mg/100 mg dry infusion) before and after simulated digestion.
| Infusion | Before Digestion | After Digestion | % Bioaccessibility a |
|---|---|---|---|
| mg/100 mg dry infusion a,b | |||
| Total hydroxycinnamic acids c/rosmarinic acid (330 nm) | |||
| A | 3.09 ± 0.02 a/1.53 ± 0.04 a | 2.71 ± 0.14 a/1.09 ± 0.03 b | 87.6 ± 4.1/71.4 ± 2.9 |
| B | 2.70 ± 0.01 a/1.92 ± 0.03 a | 2.12 ± 0.30 b/1.76 ± 0.07 a | 78.6 ± 10.8/91.9 ± 3.2 |
| C | 2.44 ± 0.06 a/1.57 ± 0.04 a | 2.09 ± 0.41 b/1.71 ± 0.02 a | 86.2 ± 19.1/108.7 ± 3.9 |
| Total flavan-3-ols d/(−)-epicatechin (270 nm) | |||
| D | 12.99 ± 0.27 a/12.23 ± 0.30 a | 12.91 ± 0.60 a/10.68 ± 0.38 a | 99.3 ± 2.2/87.3 ± 1.3 |
| E | 19.47 ± 0.60 a/13.89 ± 0.26 a | 18.35 ± 0.30 a/12.60 ± 0.16 a | 94.3 ± 2.9/90.8 ± 1.5 |
a Values are expressed as the mean ± SD; b different lower case letters within the same row for each infusion tested before and after digestion indicate significant differences according to Duncan’s test at p < 0.05; c expressed as rosmarinic acid equivalents; d expressed as (−)-epicatechin equivalents.
Figure 3RP-HPLC-DAD profile of Infusions (A–C) at 330 nm and of Infusions (D) and (E) at 270 nm before (a) and after (b) simulated digestion. Peak assignment: Peak 1, rosmarinic acid; Peak 2, (+)-catechin. Chromatographic conditions were as described in the Experimental Section.